Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis
Osteoarthritis and Cartilage · 2025-02 · 33 (2) · 207-217
DOI: 10.1016/j.joca.2024.08.014 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Osteoarthritis and Cartilage, 2025-02. Verfasst von Tiago V Pereira und 16 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Osteoarthritis, Hip, Osteoarthritis, Knee. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, Chevening, National Institute for Health Research.
Abstract (Originalsprache)
OBJECTIVE: To quantify the effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis (OA) through a systematic review and Bayesian random-effects network meta-analysis. DESIGN: We searched CENTRAL and regulatory agency websites (inception-2023) for large, English-language, randomized controlled trials (RCTs) (≥100 patients/group) examining any intra-articular intervention. PRIMARY OUTCOME: pain intensity. SECONDARY OUTCOMES: physical function and safety outcomes. Pain and function outcomes were analyzed at 2, 6, 12, 24, and 52 weeks post-randomization, and presented as standardized mean differences (SMDs) (95% credible intervals, 95% CrI). The prespecified minimal clinically important between-group difference (MID) was -0.37 SMD. Safety outcomes were presented as odds ratios (OR) (95% CrI). FINDINGS: Among 57 RCTs (22,795 participants) examining 18 intra-articular interventions, usual care or placebo, treatment effects were larger in 35 high-risk-of-bias trials than in 22 low/unclear-risk-of-bias trials. In the main analysis (excluding high-risk-of-bias trials), triamcinolone had the highest probabilities of reaching the MID at weeks 2 and 6 (75.3% and 90%, respectively) with corresponding SMDs of -0.48 (95% CrI,-0.85 to -0.10) and -0.53 (95% CrI,-0.79 to -0.27) compared to placebo (1 trial). The complex homeopathic products Tr14/Ze14 showed therapeutic potential at week 6 compared to placebo (SMD:-0.42, 95% CrI,-0.71 to -0.11, 63.5% probability of reaching the MID, 1 trial). Hyaluronic acid had no effect on pain (SMD:-0.04, 95% CrI,-0.19 to 0.11, 11 trials) but a higher risk of dropouts due to adverse events (OR: 2.01, 95% CrI,1.08 to 3.77) and serious adverse events (OR: 1.86, 95% CrI, 1.16 to 3.03) than placebo. CONCLUSION: Triamcinolone had the highest probabilities to have a treatment effect beyond the MID at weeks 2-6. Large RCTs with lower risk of bias indicate that the effects of 16 intra-articular interventions in knee or hip OA were smaller than the MID, and that most were consistent with placebo effects. Lack of evidence of long-term effectiveness underscores the need for further research beyond 24 weeks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Nuffield Department of Population Health, University of Oxford, Oxford, UK.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
- School of Physical Therapy, Western University, London, ON, Canada; Western's Bone and Joint Institute, Western University, London, ON, Canada.
- Schulich School of Medicine, University of Western Ontario, London N6A 3K7, Canada.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada; University of Zurich, Medical Faculty, CH-8091 Zurich, Switzerland.
- Institute of Ophthalmology, University College London, London, UK.
Förderung
- Canadian Institutes of Health Research
- Chevening
- National Institute for Health Research
- Canada Research Chairs
- Arthritis Society Canada
- Arthritis Society
- St. Michael's Hospital Foundation
- St. Michael’s Hospital Foundation
Zitieren
APA
Pereira, T. V., Saadat, P., Bobos, P., Iskander, S. M., Bodmer, N. S., Rudnicki, M., Dan Kiyomoto, H., Montezuma, T., Almeida, M. O., Bansal, R., Cheng, P. S., Busse, J. W., Sutton, A. J., Tugwell, P., Hawker, G. A., Jüni, P., & da Costa, B. R. (2025). Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis. Osteoarthritis and Cartilage, 33(2), 207-217. https://doi.org/10.1016/j.joca.2024.08.014
Vancouver
Pereira TV, Saadat P, Bobos P, Iskander SM, Bodmer NS, Rudnicki M, et al. Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis. Osteoarthritis and Cartilage. 2025;33(2):207-217. doi:10.1016/j.joca.2024.08.014
BibTeX
@article{Pereira2025,
author = {Pereira, Tiago V and Saadat, Pakeezah and Bobos, Pavlos and Iskander, Samir M and Bodmer, Nicolas S and Rudnicki, Martina and Dan Kiyomoto, Henry and Montezuma, Thais and Almeida, Matheus O and Bansal, Rishi and Cheng, Pai-Shan and Busse, Jason W and Sutton, Alex J and Tugwell, Peter and Hawker, Gillian A and Jüni, Peter and da Costa, Bruno R},
title = {Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis},
journal = {Osteoarthritis and Cartilage},
year = {2025},
volume = {33},
number = {2},
pages = {207--217},
doi = {10.1016/j.joca.2024.08.014}
}
EUVIMED